BioCryst Pharmaceuticals, Inc. BCRX
7.69 USD +0.06 (+0.79%)
At closeNov 6, 2026, 4:20 PM EST
7.69 0.00 0.00%
After hours · Nov 6, 4:20 PM ET
7.38 Day range 7.83
6.24 52-week range 11.11
- YTD
- -1.41%
- 1 year
- +9.39%
Revenue & Expenses
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 874.84M | 450.71M | 331.41M | 270.83M | 157.17M | |
| 855.76M | 438.44M | 326.93M | 264.23M | 149.91M | |
| 340.99M | -2.54M | -103.71M | -148.44M | -177.72M | |
| 263.86M | -88.88M | -226.54M | -247.12M | -184.06M | |
| 1.21 | -0.43 | -1.18 | -1.33 | -1.03 |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 89.94M | 104.92M | 112.45M | 306.24M | 507.73M | |
| 514.16M | 490.42M | 516.96M | 550.00M | 588.15M | |
| 633.31M | 966.35M | 972.49M | 844.60M | 695.14M | |
| 477.33M | 841.42M | 848.71M | 741.45M | 593.24M | |
| -119.15M | -475.93M | -455.53M | -294.60M | -106.99M |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 347.37M | -52.02M | -95.14M | -161.85M | -142.16M | |
| -13.69M | 52.59M | -131.50M | -128.24M | 15.80M | |
| -349.93M | -5.76M | 32.48M | 88.03M | 359.67M | |
| -2.47M | -1.12M | -2.17M | -1.35M | -2.38M | |
| -14.99M | -6.12M | -193.79M | -201.50M | 233.39M |